In humans, both homozygous and compound heterozygous mutations in TRAPPC9 (NIBP) associate with developmental delay, microcephaly (95% reported cases), and obesity (52% reported cases) [25–31]. This evidence concerns the gene TRAPPC9 and obesity due to melanocortin 4 receptor deficiency.